Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,602 across all filing types
Latest filing 2025-08-25 Interim / Quarterly Rep…
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT ON 2025 INTERIM RESULTS
Interim / Quarterly Report Classification · 1% confidence The document is an 'Announcement on 2025 Interim Results' for Sinopharm Group Co. Ltd. It contains detailed unaudited interim condensed consolidated financial statements, including the statement of profit or loss, statement of comprehensive income, and statement of financial position for the six months ended 30 June 2025. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2025
2025-08-25 English
ANNOUNCEMENT PRINCIPAL UNAUDITED FINANCIAL DATA OF CNMDC FOR THE SIX MONTHS ENDED 30 JUNE 2025
Earnings Release Classification · 1% confidence The document is a mandatory exchange announcement under HKSE rules (Rule 13.09) presenting principal unaudited financial data for the six months ended 30 June 2025. It is not the full interim report but rather an initial release of key half-year financial highlights (“principal unaudited financial data”), matching the definition of an Earnings Release (initial announcement of periodical financial results). H1 2025
2025-08-21 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-08-21 English
ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM (CNCM LTD) FOR THE SIX MONTHS ENDED 30 JUNE 2025
Earnings Release Classification · 1% confidence The document is an official regulatory announcement under HKEX Listing Rule 13.09 presenting key unaudited accounting data and financial indicators for the six months ended 30 June 2025. It is not the full interim report but rather the initial summary of half‐year results (principal data). This matches the definition of an "Earnings Release" (initial announcement of periodic financial results, key highlights only). H1 2025
2025-08-20 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-08-20 English
ANNOUNCEMENT PRELIMINARY FINANCIAL DATA OF SINOPHARM ACCORD FOR THE SIX MONTHS ENDED 30 JUNE 2025
Earnings Release Classification · 1% confidence The document is an announcement of preliminary unaudited financial data for the six months ended 30 June 2025, providing headline figures, tables of revenue, profit, per-share metrics and narrative commentary on segment performance. It is not the full interim report (which would include audited statements and detailed notes), but an initial release of half‐year results under HK listing rules. This matches the definition of an Earnings Release (ER), which is the initial announcement of periodic financial results (key highlights only). H2 2025
2025-08-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.